U.S. Entertainment Stock News

Recent share performance and business snapshot Toll Brothers (TOL) has drawn investor attention after a series of strong recent returns, including about 15% over the past month and roughly 27% in the past 3 months, alongside positive annual revenue and net income growth. The company reports annual revenue of about US$10.97b and net income of roughly US$1.35b. This reflects its position as a large US luxury homebuilder with operations spanning home construction, community amenities, and...

Green Plains (GPRE) is back in focus after analysts highlighted its carbon capture progress and the impact of 45Z tax credits, following recent earnings that showed stronger EBITDA support from these low carbon initiatives. See our latest analysis for Green Plains. After a strong run, with a 30 day share price return of 22.54% and a 90 day share price return of 41.38%, Green Plains now trades at US$13.70. A 1 year total shareholder return of 105.40% contrasts with weaker 3 and 5 year total...

Lennar (LEN) is under pressure as the housing affordability crisis forces homebuilders to cut new home prices more aggressively than existing homeowners, challenging margins and putting future earnings power under closer investor scrutiny. See our latest analysis for Lennar. The recent affordability headlines are landing on a stock that has mixed momentum, with a 7 day share price return of 7.24% and year to date share price return of 17.33%, while the 1 year total shareholder return is...

PNC Financial Services Group (NYSE:PNC) has introduced the PNC Monthly Consumer Health Check, a new data product using proprietary, anonymized data on U.S. consumer activity. The series is designed to offer real time insights on consumer trends and the broader U.S. economy for business leaders, investors and households. For investors watching NYSE:PNC, this move comes with the stock at a recent share price of $229.32 and a 1 year return of 22.6%. Over 3 years and 5 years, the stock shows...

Essent Group (ESNT) has posted its latest FY 2025 numbers, with Q3 total revenue at US$311.8 million and basic EPS of US$1.69, backed by net income of US$164.2 million. The company has seen quarterly revenue range between US$312.9 million and US$344.4 million over the last six reported periods, while basic EPS has moved between US$1.60 and US$1.95 over the same stretch, giving investors a clear view of how the top line and EPS have tracked together through recent quarters. Set against a...

Allegiant Travel Company recently reported its fourth-quarter and full-year 2025 results, with quarterly revenue rising to US$656.19 million and net income reaching US$31.94 million, compared with a very large net loss a year earlier. For 2025 as a whole, Allegiant’s net loss narrowed to US$44.70 million from US$240.24 million, with losses per share from continuing operations shrinking significantly, highlighting a sharp improvement in the company’s profitability profile. We’ll now examine...

Ryan Specialty Holdings (RYAN) has wrapped up FY 2025 with fourth quarter revenue of US$751.2 million and basic EPS of US$0.06, while trailing twelve month EPS sits at US$0.50 on revenue of about US$3.1 billion, alongside trailing earnings growth of 126.2% and a net margin of 7.0% compared with 3.9% a year earlier. The company has seen quarterly revenue move from US$649.4 million and EPS of US$0.04 in Q4 2024 to US$751.2 million and EPS of US$0.06 in Q4 2025, against a backdrop of five year...

In early February 2026, Goodyear Tire & Rubber reported Q4 2025 results showing sales of US$4,917 million and net income of US$105 million, while posting a full-year 2025 net loss of US$1.72 billion on sales of US$18.28 billion. Despite the annual loss, Goodyear highlighted record segment operating income, completion of its "Goodyear Forward" transformation with US$1.50 billion in savings, major asset sales that reduced net debt, and plans for 1,700 new premium-focused product...

Viking Therapeutics (VKTX) has drawn investor attention after recent share performance data highlighted a mixed picture, with a 1 day return of about a 5% decline and a very large 3 year total return multiple. See our latest analysis for Viking Therapeutics. At the current share price of US$29.00, Viking Therapeutics has seen mixed momentum, with a 7 day share price return of 1.97%, a 30 day share price decline of 15.55%, and a 3 year total shareholder return of about 2.6x. Together, these...

New York Times (NYT) shares are in focus after the company reported fourth quarter and full year 2025 results, highlighted by higher revenue and net income, as well as completed buybacks and an increased quarterly dividend. See our latest analysis for New York Times. At a share price of $72.94, New York Times has seen momentum build recently, with a 7-day share price return of 7.09% and a 90-day share price return of 14.08%, alongside a 1-year total shareholder return of 48.48% that reflects...

In early February 2026, Fortinet reported full-year 2025 results showing revenue of US$6,799.6 million and net income of US$1,853.4 million, alongside new 2026 revenue guidance of US$7,500–7,700 million and an expanded share repurchase authorization to US$10.25 billion. Beyond the headline earnings and buyback, Fortinet’s AI-enhanced FortiSIEM upgrade underscores how product innovation is becoming central to its cybersecurity platform appeal. We’ll now examine how Fortinet’s upbeat 2026...

Pony.ai, in partnership with Toyota Motor China and GAC Toyota, has started mass production and commercial rollout of the bZ4X Robotaxi fleet in major Chinese cities. The company is moving from pilot programs to scaled robotaxi operations using Toyota's bZ4X electric vehicle platform. Pony.ai, listed as NasdaqGS:PONY, has become the first robotaxi company to be included in the MSCI China Index. The MSCI China Index inclusion signals growing institutional attention on Pony.ai within global...

In early February 2026, Azenta, Inc. reported first-quarter revenue of US$148.64 million with a wider net loss of US$15.43 million, reiterated full-year 2026 organic revenue growth guidance of 3% to 5%, and disclosed no repurchases under its recently authorized buyback. Days later, Azenta revealed a new partnership with Frontier Space to test its FluidX 0.26mL tubes on the EGGS-2 microgravity mission, extending its sample-management technologies into space-based life sciences research and...

Vertiv Holdings Co (NYSE:VRT) reported record fourth quarter results, supported by strong demand tied to AI and data center projects. The company highlighted a record US$15b order backlog and a large rise in organic orders tied to AI-centric infrastructure. Vertiv is expanding production capacity and working on liquid cooling and prefabricated AI data center systems as part of its growth plans. Management issued what it described as strong forward-looking guidance, reflecting expectations...

Vital Farms (VITL) is back on investor radars after reporting a 37.2% year-over-year rise in quarterly revenue, sharply higher earnings per share, and valuation grades suggesting a discount, despite slightly lower consensus earnings estimates. See our latest analysis for Vital Farms. That backdrop helps explain recent trading, with the share price at US$28.41 after a 2.53% 1 day share price return and 5.81% 7 day share price return, even as the 1 year total shareholder return sits at an...

In recent days, Energy Transfer outlined plans for US$5.0 billion to US$5.5 billion of 2026 capital spending and projected high single-digit adjusted EBITDA growth, while analysts raised near-term earnings and revenue estimates ahead of its now-past February 17 fourth-quarter results. This combination of sizable growth investment and more optimistic analyst forecasts highlights how Energy Transfer’s fee-based midstream model underpins expectations for stronger future cash generation. With...

In early February 2026, ACADIA Pharmaceuticals reported that the EMA’s CHMP issued a negative trend vote on its Marketing Authorization Application for trofinetide (DAYBUE) in Rett syndrome, and the company now plans to formally seek a re-examination under EU procedures. This setback highlights the regulatory hurdles ACADIA faces in bringing DAYBUE to European patients, even as it is already commercialized elsewhere for Rett syndrome. We’ll now examine how the CHMP’s negative trend vote and...

In its most recent quarter ended December 31, 2025, STERIS plc reported higher sales of US$1,496.2 million and net income of US$192.9 million, alongside completing a US$350.6 million share repurchase program totaling 1,507,158 shares since May 2023. The combination of rising earnings per share and ongoing margin pressure from tariffs and inflation highlights a tension between growth in profitability metrics and the cost environment facing STERIS. We’ll now examine how STERIS’s margin...

Phillips 66 (NYSE:PSX) reports record operational performance in 2025, including high natural gas transportation and fractionation volumes. The company completes a major portfolio shift in 2025, selling its European retail business and acquiring the remaining interest in WRB. Midstream assets see further buildout, while refining operations are reported as improved during this period. For you as an investor, 2025 marks a clear turning point in how Phillips 66 (NYSE:PSX) is set up across...

If you are wondering whether Deckers Outdoor is priced attractively right now, the next sections will walk through what the current share price could imply about its underlying value. The stock has been relatively steady over the last 7 days at 0.2%, after a 14.1% move over 30 days, an 8.4% return year to date, a 25.4% decline over 1 year, and gains of 71.3% and 109.7% over 3 and 5 years respectively. These mixed returns set the backdrop for our valuation review, as longer term gains sit...

NextEra Energy (NYSE:NEE) received PJM board approval for a 220 mile, 765 kV transmission line developed with Exelon, aimed at expanding grid capacity and reliability across multiple regions. The company also signed a memorandum of understanding with Xcel Energy to deliver power to large load customers, including data centers with rapidly rising electricity needs. These moves target growing demand for dependable, large scale power and position NextEra Energy as a key player in supporting new...

Pulmovant, a Roivant company, has completed patient enrollment ahead of schedule in the Phase 2 PHocus trial of mosliciguat in pulmonary hypertension associated with interstitial lung disease (PH-ILD). Roivant Sciences (NasdaqGS:ROIV) has reported new positive Phase 2 data for brepocitinib in cutaneous sarcoidosis. Both updates reflect ongoing clinical activity in areas of high unmet medical need across Roivant’s pipeline. Roivant Sciences, traded as NasdaqGS:ROIV, focuses on developing and...

Dell Technologies (DELL) is sitting at an interesting crossroads, with record interest in its AI server products alongside pressure from a global memory chip shortage and cautious margin commentary ahead of upcoming earnings. See our latest analysis for Dell Technologies. Recent news has swung between optimism around Dell Technologies' record AI server demand and caution on margins as memory costs rise. The share price reflects that mix, with a 4.1% gain in the last session contrasting with a...

Millrose Properties stock moves on improving fundamentals Millrose Properties (MRP) has drawn fresh attention after recent share price gains, with the stock up 1.7% in the past day and about 5% over the past month. That interest comes as Millrose reports annual revenue of US$410.96m and net income of US$216.783m, implying a business that currently converts a meaningful share of its top line into profit. See our latest analysis for Millrose Properties. At the current share price of US$31.97,...